Biontech Se Drn Stock Total Asset

B1NT34 Stock  BRL 33.03  3.03  10.10%   
BIONTECH SE DRN fundamentals help investors to digest information that contributes to BIONTECH's financial success or failures. It also enables traders to predict the movement of BIONTECH Stock. The fundamental analysis module provides a way to measure BIONTECH's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BIONTECH stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

BIONTECH SE DRN Company Total Asset Analysis

BIONTECH's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.

Total Asset

 = 

Tangible Assets

+

Intangible Assets

More About Total Asset | All Equity Analysis

Current BIONTECH Total Asset

    
  15.83 B  
Most of BIONTECH's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BIONTECH SE DRN is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
Competition

Based on the latest financial disclosure, BIONTECH SE DRN has a Total Asset of 15.83 B. This is 110.53% higher than that of the Healthcare sector and significantly higher than that of the Biotechnology industry. The total asset for all Brazil stocks is 46.27% higher than that of the company.

BIONTECH Total Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BIONTECH's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BIONTECH could also be used in its relative valuation, which is a method of valuing BIONTECH by comparing valuation metrics of similar companies.
BIONTECH is currently under evaluation in total asset category among related companies.

BIONTECH Fundamentals

About BIONTECH Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze BIONTECH SE DRN's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BIONTECH using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BIONTECH SE DRN based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BIONTECH SE DRN. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
Note that the BIONTECH SE DRN information on this page should be used as a complementary analysis to other BIONTECH's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Complementary Tools for BIONTECH Stock analysis

When running BIONTECH's price analysis, check to measure BIONTECH's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIONTECH is operating at the current time. Most of BIONTECH's value examination focuses on studying past and present price action to predict the probability of BIONTECH's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BIONTECH's price. Additionally, you may evaluate how the addition of BIONTECH to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
CEOs Directory
Screen CEOs from public companies around the world
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Bonds Directory
Find actively traded corporate debentures issued by US companies
Please note, there is a significant difference between BIONTECH's value and its price as these two are different measures arrived at by different means. Investors typically determine if BIONTECH is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BIONTECH's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.